# SinoMab Bioscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sinomab-bioscience

- Industry: Biotechnology
- Headquarters: Hong Kong, Hong Kong SAR - China
- Website: www.sinomab.com
- Latest round: Series C (Jan 1, 2018)
- Investors on record: 1

## About

Founded in 2001 and based in Hong Kong, SinoMab Bioscience Limited researches on, develops, manufactures, and markets immunotherapies for treating rheumatoid arthritis.

## Funding rounds

- Series C, Jan 1, 2018 — Apricot Capital

## Investors

- Apricot Capital (https://capitalatlas.ai/funds/apricot-capital) — Series C